Detalhe da pesquisa
1.
Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.
Clin Infect Dis
; 76(3): e1177-e1185, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36164254
2.
Pharmacokinetics, Safety, and Efficacy of an Allometric Miltefosine Regimen for the Treatment of Visceral Leishmaniasis in Eastern African Children: An Open-label, Phase II Clinical Trial.
Clin Infect Dis
; 68(9): 1530-1538, 2019 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30188978
3.
Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study.
PLoS Negl Trop Dis
; 17(11): e0011780, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37988402
4.
Innovative approaches to clinical data management in resource limited settings using open-source technologies.
PLoS Negl Trop Dis
; 8(9): e3134, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25210976